Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology-Oncology Unit: A 10-Year Study.
Gram-negative
Gram-positive
bacteremia
bloodstream infection
empirical antibiotic therapy
multidrug resistance organism
neutropenia
neutropenic fever
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
08 Feb 2022
08 Feb 2022
Historique:
received:
23
12
2021
revised:
24
01
2022
accepted:
03
02
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
16
2
2022
Statut:
epublish
Résumé
Bloodstream infections (BSIs) after chemotherapy or hematopoietic stem cell transplantation (HSCT) are a leading cause of morbidity and mortality. Data on 154 BSIs that occurred in 111 onco-hematological patients (57 hematological malignancies, 28 solid tumors, and 26 non-malignant hematological diseases) were retrospectively collected and analyzed. Monomicrobial Gram-positive (GP), Gram-negative (GN), and fungal BSIs accounted for 50% (77/154), 38.3% (59/144), and 3.2% (5/154) of all episodes. Polymicrobial infections were 7.8% (12/154), while mixed bacterial-fungal infections were 0.6% (1/154). The most frequent GN isolates were
Identifiants
pubmed: 35160334
pii: jcm11030880
doi: 10.3390/jcm11030880
pmc: PMC8836920
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Lab Physicians. 2015 Jul-Dec;7(2):116-20
pubmed: 26417163
Antibiotics (Basel). 2021 Mar 05;10(3):
pubmed: 33807654
PLoS One. 2018 Jun 28;13(6):e0199531
pubmed: 29953464
Infect Dis Clin North Am. 2007 Dec;21(4):1055-90, x
pubmed: 18061089
J Antimicrob Chemother. 2020 Dec 1;75(12):3665-3674
pubmed: 32865203
Epidemiol Infect. 2019 Nov 08;147:e298
pubmed: 31699182
J Infect. 2014 Apr;68(4):321-31
pubmed: 24370562
JAMA Pediatr. 2013 Oct;167(10):903-10
pubmed: 23921724
Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):841-50
pubmed: 23354675
Int J Infect Dis. 2018 Jun;71:59-64
pubmed: 29649549
Haematologica. 2013 Dec;98(12):1826-35
pubmed: 24323983
Infect Dis Ther. 2021 Jun;10(2):789-800
pubmed: 33704685
Open Forum Infect Dis. 2020 Sep 30;7(11):ofaa461
pubmed: 33209951
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Haematologica. 2010 Sep;95(9):1612-5
pubmed: 20305140
Nat Rev Microbiol. 2015 Jan;13(1):42-51
pubmed: 25435309
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Infect Dis. 2004 Jul 15;39 Suppl 1:S25-31
pubmed: 15250017
Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S331-4
pubmed: 25352626
J Pediatr Hematol Oncol. 2019 Jul;41(5):e271-e276
pubmed: 31033794
Clin Infect Dis. 2020 Mar 3;70(6):1068-1074
pubmed: 31321410
J Infect Public Health. 2019 May - Jun;12(3):364-366
pubmed: 30594483
Clin Infect Dis. 2001 Oct 1;33(7):947-53
pubmed: 11528564
Clin Microbiol Infect. 2015 Apr;21(4):337-43
pubmed: 25595706
Virulence. 2016 Apr 2;7(3):280-97
pubmed: 27002635
Clin Microbiol Rev. 2012 Oct;25(4):682-707
pubmed: 23034326
Transplantation. 2010 Sep 15;90(5):581-7
pubmed: 20585281
Clin Microbiol Infect. 2013 May;19(5):474-9
pubmed: 22524597
Br J Haematol. 2016 Feb;172(4):497-511
pubmed: 26492511
Pediatr Rev. 2008 Jan;29(1):12-23; quiz 24
pubmed: 18166617
Clin Microbiol Infect. 2019 Aug;25(8):943-950
pubmed: 31004767
Intensive Care Med. 2014 Jan;40(1):41-9
pubmed: 24231857
Clin Infect Dis. 2003 May 1;36(9):1103-10
pubmed: 12715303
Int J Antimicrob Agents. 2018 Apr;51(4):548-553
pubmed: 29277528
Future Sci OA. 2020 Jan 27;6(3):FSO438
pubmed: 32140243
J Clin Oncol. 2017 Jun 20;35(18):2082-2094
pubmed: 28459614